We examine the differential responses of PN- and MES-like cells from the same tumor to BMP4, with a focus on the role of the cyclin-dependent kinase (CDK) inhibitor p21Waf1/Cip1 (p21) in this process. The gene discussed is BMP4; the disease is neoplasm.